Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-11

FDA Approved: OXCARBAZEPINE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' original ANDA for oxcarbazepine, a generic anticonvulsant indicated for partial seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

ORIG AP for OXCARBAZEPINE (OXCARBAZEPINE)